Shorla Oncology, a specialty pharmaceutical company, is developing innovative oncology drugs for cancer, with a focus on women's, pediatric, and rare cancers. They have launched Nelarabine and JYLAMVO for leukemia treatment and are awaiting FDA review for their novel formulation to treat breast and ovarian cancer.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
HSE and GP apologize for delayed treatment of child who swallowed batteryThe HSE and a general practitioner have apologized to a woman for the treatment her son received after he swallowed a battery. Aaron Sikorski was 13-months-old when he swallowed the button-type battery while playing at home. The High Court heard it was 9½ days before a chest X-ray was carried out despite visits to his GP and the emergency department at Galway University Hospital.
Source: IrishTimes - 🏆 3. / 98 Read more »